Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

SK Biopharmaceuticals Launches Cenobamate in Japan

SK Biopharmaceuticals has completed launches in all three Northeast Asian countries as its innovative epilepsy treatment cenobamate officially entered the Japanese market.

  • SK Biopharmaceuticals launches epilepsy drug cenobamate in Japan.
  • Drug available under brand name Ekiscorpri starting November 13.
  • Cenobamate shows higher seizure freedom rate in clinical trials.

More from Friday 13 November →